EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 356 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,866,000 | +5.0% | 42,911 | +20.9% | 0.01% | 0.0% |
| Q3 2021 | $1,777,000 | -24.3% | 35,502 | -4.7% | 0.01% | -36.4% |
| Q2 2021 | $2,347,000 | -54.9% | 37,259 | -33.5% | 0.01% | -59.3% |
| Q1 2021 | $5,202,000 | -11.5% | 55,998 | -14.7% | 0.03% | -20.6% |
| Q4 2020 | $5,881,000 | +44.0% | 65,629 | +66.0% | 0.03% | +30.8% |
| Q3 2020 | $4,085,000 | +25.6% | 39,532 | -3.9% | 0.03% | +18.2% |
| Q2 2020 | $3,252,000 | +6.9% | 41,121 | -21.8% | 0.02% | -12.0% |
| Q1 2020 | $3,042,000 | +81.7% | 52,574 | +69.4% | 0.02% | +108.3% |
| Q4 2019 | $1,674,000 | -35.6% | 31,036 | -37.6% | 0.01% | -42.9% |
| Q3 2019 | $2,599,000 | +21.8% | 49,727 | +12.6% | 0.02% | +23.5% |
| Q2 2019 | $2,133,000 | +10.3% | 44,150 | +15.3% | 0.02% | 0.0% |
| Q1 2019 | $1,933,000 | – | 38,276 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,080,519 | $44,336,000 | 4.65% |
| GREAT POINT PARTNERS LLC | 290,000 | $6,180,000 | 2.65% |
| FIDUCIARY MANAGEMENT ASSOCIATES LLC | 651,884 | $13,892,000 | 0.99% |
| Matarin Capital Management, LLC | 85,003 | $1,811,414,000 | 0.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 407,000 | $8,673,000 | 0.39% |
| ICON ADVISERS INC/CO | 258,478 | $5,508,000 | 0.32% |
| RMB Capital Management, LLC | 178,204 | $3,798,000 | 0.23% |
| NEW AMSTERDAM PARTNERS LLC/NY | 159,470 | $3,398,000 | 0.23% |
| GLOBEFLEX CAPITAL L P | 94,016 | $2,003,000 | 0.23% |
| Convergence Investment Partners, LLC | 58,672 | $1,250,000 | 0.17% |